Dual antiplatelet agent failure: A new syndrome or clinical honentity?

被引:9
作者
Barnes, Geoffrey D. [1 ]
Li, Jin [1 ]
Kline-Rogers, Eva [1 ]
Vedre, Ameeth [1 ]
Armstrong, David F. [1 ]
Froehlich, James B. [1 ]
Eagle, Kim A. [1 ]
Gurm, Hitinder S. [1 ]
机构
[1] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA
关键词
D O I
10.1016/j.ahj.2007.06.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Aspirin resistance is a well-documented,laboratory finding, but the effects of clinical aspirin (ASA) failure on patients with acute coronary syndrome (ACS) have been debated. Likewise, there is recognition of clopidogrel resistance, but the clinical effects of clopidogrel failure are not well understood. We sought to determine the 6-month outcomes of patients who developed an ACS while on ASA or dual antiplatelet agents. Methods Of all patients admitted to the University of Michigan, Ann Arbor, between 1999 and 2005 with a diagnosis of ACS, 6-month follow-up data were available for 3126. The cohort was divided into 3 groups based on medication history: no prior antiplatelet agent, ASA only, and ASA with clopidogrel (or ticlopidine). Primary end point was the rate of death, myocardial infarction, and stroke, or composite major adverse cardiac events (MACEs) at 6 months. Results Aside from a lower rate of myocardial infarction in patients without any prior antiplatelet agent use, there were no significant differences in 6-month stroke, death, or MACE between the 3 medication cohorts. In the propensity-adjusted model, whereas dual antiplatelet status was not an independent predictor of 6-month mortality or MACE, there was a trend toward lower 6-month death rates for patients with prior ASA use (odds ratio 0.72, 95% Cl 0.51-1.04, P =.08). Conclusions Patients who "fail" antiplatelet therapy do not have overall worse. prognosis. Our data do not support ASA or dual antiplatelet agent failure as a distinct clinical entity.
引用
收藏
页码:732 / 735
页数:4
相关论文
共 11 条
  • [1] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [2] ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)
    Braunwald, E
    Antman, EM
    Beasley, JW
    Califf, RM
    Cheitlin, MD
    Hochman, JS
    Jones, RH
    Kereiakes, D
    Kupersmith, J
    Levin, TN
    Pepine, CJ
    Schaeffer, JW
    Smith, EE
    Steward, DE
    Theroux, P
    Gibbons, RJ
    Alpert, JS
    Faxon, DP
    Fuster, V
    Gregoratos, G
    Hiratzka, LF
    Jacobs, AK
    Smith, SC
    [J]. CIRCULATION, 2002, 106 (14) : 1893 - 1900
  • [3] Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
    Chen, ZM
    Jiang, LX
    Chen, YP
    Xie, JX
    Pan, HC
    Peto, R
    Collins, R
    Liu, LS
    Chen, ZM
    Liu, LS
    Collins, R
    Jiang, LX
    Chen, YP
    Xie, JX
    Pan, HC
    Peto, R
    Cai, NS
    Chen, YZ
    Cui, JJ
    Dai, GZ
    Feng, JZ
    Fu, SY
    Gent, M
    Gong, LS
    Hu, DY
    Huang, DJ
    Huang, J
    Huang, TG
    Huang, ZW
    Hui, RT
    Jiang, BQ
    Li, DY
    Li, SM
    Li, TD
    Li, YQ
    Li, ZQ
    Liu, YH
    Meng, QY
    Qian, TJ
    San, J
    Tao, SQ
    Wang, DW
    Wang, LH
    Wang, W
    Wu, HA
    Xi, WH
    Xu, CB
    Yang, DC
    Yang, XF
    Yin, JQ
    [J]. LANCET, 2005, 366 (9497) : 1607 - 1621
  • [4] D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
  • [5] 2-B
  • [6] A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
    Gum, PA
    Kottke-Marchant, K
    Welsh, PA
    White, J
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 961 - 965
  • [7] Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention - The role of dual drug resistance
    Lev, EI
    Patel, RT
    Maresh, KJ
    Guthikonda, S
    Granada, J
    DeLao, T
    Bray, PF
    Kleiman, NS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) : 27 - 33
  • [8] Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction
    Portnay, EL
    Foody, JM
    Rathore, SS
    Wang, YF
    Masoudi, FA
    Curtis, JP
    Krumholz, HM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (06) : 967 - 974
  • [9] SANATINE MS, 2003, J AM COLL CARDIOL, V41, pS89
  • [10] Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
    Steinhubl, SR
    Berger, PB
    Mann, JT
    Fry, ETA
    DeLago, A
    Wilmer, C
    Topol, EJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19): : 2411 - 2420